COPD is a chronic respiratory disease, often associated with extrapulmonary manifestations. Co-morbidities, including anxiety, depression and cognitive impairment, worsen its progression and quality of life. The prevalence of these disorders is high, yet they are often poorly understood and inadequately managed. In the development of psychological disorders, there is accumulated evidence highlighting the major role of systemic inflammation, as well as chronic disease, genetics, the consequences of smoking, hypoxaemia, oxidative stress, and the gut microbiome In addition to traditional treatments such as bronchodilatator medications, respiratory rehabilitation and smoking cessation, systemic inflammation is an interesting therapeutic target, with the use of anti-inflammatory drugs, anti-cytokines, and nutritional interventions.
Keywords: BPCO; COPD; Cognitive disorders; Depression; Dépression; Inflammation systémique; Psychiatric disorders; Systemic inflammation; Troubles cognitifs; Troubles psychiatriques.
Copyright © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.